- HYTN Cannabis Inc., has received a license amendment from Health Canada allowing for the cultivation of cannabis
- Controlling cannabis cultivars, as well as subsequent cultivation, curing and processing, is foundational to elevating the cannabis experience for consumers
- HYTN formulates, manufactures, markets, and sells cannabis goods
- HYTN Innovations Inc. (HYTN) opened trading at C$0.145 per share
HYTN Innovations’ (HYTN) subsidiary, HYTN Cannabis has received a license amendment from Health Canada allowing for the cultivation of cannabis.
The company’s Chief Operating Officer, Jason Broome commented that while sourcing dry flower and downstream cannabis form factors for their infused cannabis products, the company asked its suppliers to only provide inputs that meet HYTN’s exacting specifications.
“Consistently finding inputs that meet the standard has been a challenge. However, through that challenge, we have found an opportunity to further advance our mission of elevating the cannabis experience by controlling where it begins, specifically with the cannabis plant itself. Having now secured our cultivation license, our plan is to partner with Okanagan-based cannabis breeders to create a library of exceptional cultivars, which will be held in tissue culture at our Kelowna facility, and to micro-propagate those cultures, providing cultivation partners with hand-selected monocultures, who will grow them out to flower and harvest and cure them under our Quality Management System. Okanagan cannabis breeders and the cultivars they have created are elite and among the best in the world. We look forward to securing quality inputs through our partnerships with such breeders, growers and processors using our hand selected cultivars.”
HYTN Chief Executive Officer, Elliot McKerr added that controlling cannabis cultivars, as well as subsequent cultivation, curing and processing, is foundational to elevating the cannabis experience for consumers.
“Securing a cultivation license allows us to build our tissue culture program in our Kelowna facility. We see this as core to entrenching HYTN as a leader of cannabis innovation and ensuring superior and elevated cannabis experiences every time a consumer chooses the HYTN brand.”
HYTN formulates, manufactures, markets, and sells cannabis goods.
HYTN Innovations Inc. (HYTN) opened trading at C$0.145 per share.